Pennsylvania SB 696: An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.

Status: Referred to Banking & Insurance (as of 2023-05-15)

State: Pennsylvania · Session: 2023-2024 · Bill: SB 696

Sponsors: Sharif Street, Amanda Cappelletti, Daniel Laughlin, Jay Costa, Jimmy Dillon, Maria Collett, Timothy Kearney, Vincent Hughes, Wayne Fontana

View Pennsylvania SB 696 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.